Anxiety responses and neurochemical changes in a kaolin-induced rat model of hydrocephalus: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 7, Issue 4, 2011, Pages 401-407

  Hwang, Yong Sup ^a,c   Shim, Insop ^b,d   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c MI Tech Co Ltd   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Anxiety response; Dopamine; Elevated plus maze; Hydrocephalus; Kaolin; Rat model

Indexed keywords

CHOLECYSTOKININ; KAOLIN; NEUROPEPTIDE Y; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN TISSUE; CISTERNA MAGNA; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MAZE TEST; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; ANXIETY; BRAIN CHEMISTRY; CEREBRAL VENTRICLES; CHOLECYSTOKININ; CISTERNA MAGNA; DOPAMINE; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; INJECTIONS; KAOLIN; MALE; NEUROPEPTIDE Y; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 79953816976     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2011.1.PEDS10182     Document Type: Article

References (37)

1. Aigner TG, Mishkin M: The effects of physostigmine and scopolamine on recognition memory in monkeys. Behav Neural Biol 45:81-87, 1986 (Pubitemid 16162297)
2. Aronin PA, Kerrick R: Value of dynamometry in assessing upper extremity function in children with myelomeningocele. Pediatr Neurosurg 23:7-13, 1995
3. Beninger RJ: The role of dopamine in locomotor activity and learning. Brain Res 287:173-196, 1983
4. Bret P, Chazal J: Chronic ("normal pressure") hydrocephalus in childhood and adolescence. A review of 16 cases and reappraisal of the syndrome. Childs Nerv Syst 11:687-691, 1995
5. Britton KT, Akwa Y, Spina MG, Koob GF: Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze. Peptides 21:37-44, 2000 (Pubitemid 30126040)
6. Chang JW, Lee BH, Lee MS, Chang JH, Park YG, Chung SS: Microelectrode recording-guided deep brain stimulation in patients with movement disorders (first trial in Korea), in Kultas-Ilinsky K, Ilinsky IA (eds): Basal Ganglia and Thalamus in Health and Movement Disorders. New York: Kluwer Academic/Plenum Publishers, 2001, pp 341-347
7. Cosan TE, Guner AI, Akcar N, Uzuner K, Tel E: Progressive ventricular enlargement in the absence of high ventricular pressure in an experimental neonatal rat model. Childs Nerv Syst 18:10-14, 2002 (Pubitemid 41522960)
8. da Silva MC: Pathophysiology of hydrocephalus, in Cinalli G, Maixner WJ, Sainte-Rose C (eds): Pediatric Hydrocephalus. Milan: Springer-Verlag Italia, 2004, pp 65-77
9. da Silva MC, Drake JM, Lemaire C, Cross A, Tuor UI: High-energy phosphate metabolism in a neonatal model of hydrocephalus before and after shunting. J Neurosurg 81:544-553, 1994 (Pubitemid 24303280)
10. da Silva MC, Michowicz S, Drake JM, Chumas PD, Tuor UI: Reduced local cerebral blood flow in periventricular white matter in experimental neonatal hydrocephalus-restoration with CSF shunting. J Cereb Blood Flow Metab 15:1057-1065, 1995
11. Dawson GR, Tricklebank MD: Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33-36, 1995
12. de Oliveira AR, Reimer AE, Brandão ML: Role of dopamine receptors in the ventral tegmental area in conditioned fear. Behav Brain Res 199:271-277, 2009
13. Del Bigio MR: Neuropathological changes caused by hydrocephalus. Acta Neuropathol 85:573-585, 1993
14. Del Bigio MR, Vriend JP: Monoamine neurotransmitters and amino acids in the cerebrum and striatum of immature rats with kaolin-induced hydrocephalus. Brain Res 798:119-126, 1998 (Pubitemid 28342027)
15. File SE: Behavioural detection of anxiolytic action, in Elliott JM, Heal DJ, Marsden CA (eds): Experimental Approaches to Anxiety and Depression. Chichester: John Wiley & Sons, 1992, pp 25-44
16. Frye CA, Paris JJ: Infusions of bicuculline to the ventral tegmental area attenuates sexual, exploratory, and anti-anxiety behavior of proestrous rats. Pharmacol Biochem Behav 93:474-481, 2009
17. Groves PM: A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res 286:109-132, 1983
18. Hwang YS, Shim I, Chang JW: The behavioral change of locomotor activity in a kaolin-induced hydrocephalus rat model: evaluation of the effect on the dopaminergic system with progressive ventricle dilatation. Neurosci Lett 462:198-202, 2009
19. Ishizaki R, Tashiro Y, Inomoto T, Hashimoto N: Acute and subacute hydrocephalus in a rat neonatal model: correlation with functional injury of neurotransmitter systems. Pediatr Neurosurg 33:298-305, 2000 (Pubitemid 32153945)
20. Jang S, Kim D, Lee Y, Moon S, Oh S: Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. Neurochem Res 36:258-267, 2011
21. Kim H, Whang WW, Kim HT, Pyun KH, Cho SY, Hahm DH, et al: Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Res 983:201-208, 2003 (Pubitemid 36952581)
22. Kito Y, Kazui H, Kubo Y, Yoshida T, Takaya M, Wada T, et al: Neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus. Behav Neurol 21:165-174, 2009
23. Laurence KM, Coates S: Further thoughts on the natural history of hydrocephalus. Dev Med Child Neurol 4:263-267, 1962
24. Lee B, Shim I, Lee HJ, Yang Y, Hahm DH: Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci Lett 453:151-156, 2009
25. Marsden CD: Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease. Can J Neurol Sci 11 (1 Suppl):129-135, 1984
26. McAllister JP II, Chovan P: Neonatal hydrocephalus. Mechanisms and consequences. Neurosurg Clin N Am 9:73-93, 1998
27. Park HJ, Chae Y, Jang J, Shim I, Lee H, Lim S: The effect of acupuncture on anxiety and neuropeptide Y expression in the basolateral amygdala of maternally separated rats. Neurosci Lett 377:179-184, 2005 (Pubitemid 40332352)
28. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 4. San Diego: Academic Press, 1998
29. Rotzinger S, Lovejoy DA, Tan LA: Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31:736-756, 2010
30. Sanberg PR, Coyle JT: Scientific approaches to Huntington's disease. CRC Crit Rev Clin Neurobiol 1:1-44, 1984 (Pubitemid 15222963)
31. Shim IS, Ha Y, Chung JY, Lee HJ, Yang KH, Chang JW: Association of learning and memory impairments with changes in the septohippocampal cholinergic system in rats with kaolin-induced hydrocephalus. Neurosurgery 53:416-425, 2003 (Pubitemid 36950923)
32. Shurtleff DB, Foltz EL, Loeser JD: Hydrocephalus. A definition of its progression and relationship to intellectual function, diagnosis, and complications. Am J Dis Child 125:688-693, 1973
33. Stanford SC: Anxiety, in Webster RA (ed): Neurotransmitters, Drugs and Brain Function. Chichester: John Wiley & Sons, 2001, pp 395-423
34. Tashiro Y, Drake JM: Reversibility of functionally injured neurotransmitter systems with shunt placement in hydrocephalic rats: implications for intellectual impairment in hydrocephalus. J Neurosurg 88:709-717, 1998 (Pubitemid 28145215)
35. Tashiro Y, Drake JM, Chakrabortty S, Hattori T: Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus. Brain Res 770:45-52, 1997
36. Thompson NM, Fletcher JM, Chapieski L, Landry SH, Miner ME, Bixby J: Cognitive and motor abilities in preschool hydrocephalics. J Clin Exp Neuropsychol 13:245-258, 1991
37. Webster RA: Dopamine, in Webster RA (ed): Neurotransmitters, Drugs and Brain Function. Chichester: John Wiley & Sons, 2001, pp 137-161